RhumbLine Advisers’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-250
| Closed | -$537 | – | 4201 |
|
|
2024
Q2 | $537 | Hold |
250
| – | – | ﹤0.01% | 4286 |
|
|
2024
Q1 | $812 | Hold |
250
| – | – | ﹤0.01% | 4161 |
|
|
2023
Q4 | $5.12K | Hold |
250
| – | – | ﹤0.01% | 3982 |
|
|
2023
Q3 | $4.02K | Sell |
250
-1,427
| -85% | -$22.9K | ﹤0.01% | 4017 |
|
|
2023
Q2 | $14.3K | Sell |
1,677
-10,033
| -86% | -$85.3K | ﹤0.01% | 3863 |
|
|
2023
Q1 | $116K | Buy |
11,710
+1,628
| +16% | +$16.1K | ﹤0.01% | 2836 |
|
|
2022
Q4 | $96K | Buy |
+10,082
| New | +$96K | ﹤0.01% | 2909 |
|